Steve Brine MP

for Winchester & Chandler's Ford

14 JAN 2015

Local MP backs Duchenne treatment campaign

Winchester & Chandler's Ford MP Steve Brine has joined the fight for urgent access to a new rare disease treatment.

The campaign calls on NHS England to end delays to a breakthrough treatment which will allow some boys affected by a devastating muscle-wasting condition to stay on their feet for longer.

On Wednesday 14th January, Steve Brine joined fellow MPs and families as they were calling for fast access to a new pioneering drug for Duchenne muscular dystrophy. The condition causes irreversible muscle damage, with many boys needing a wheelchair by the time they are eight or nine years old. Problems with heart and lung muscles mean that few with the condition currently live to see their 30th birthday.

Translarna, the first drug of its kind in the UK, will allow some boys living with Duchenne muscular dystrophy, to stay on their feet for longer. Translarna has been designed for 10-15 percent of the 2,500 children and adults in the UK who have Duchenne muscular dystrophy caused by a 'nonsense' or 'stop' mutation. Countries including Spain, Germany, Italy and Denmark already have access to Translarna, but NHS administrative issues have led to agonising delays for families in the UK.

To be eligible for the treatment, Translarna, these boys must still be able to walk. Each day this treatment is delayed results in a greater risk that they could miss out on the drug entirely.

Steve Brine MP said: "A bureaucratic internal debate is currently preventing licensing of the drug Translarna, which can give these boys precious extra time on their feet.

"NHS England urgently needs to come up with a short-term solution as families affected by Duchenne muscular dystrophy do not have a single day to spare as their sons get weaker each day."

Robert Meadowcroft, Chief Executive of the Muscular Dystrophy Campaign, said:

"We greatly appreciate Steve Brine's support on this issue. Translarna is a long-awaited breakthrough. We must see an end to the delays in this drug reaching children who desperately need it.

"NHS administrative delays cannot lead to a situation in which even one child becomes ineligible for a drug that could have made a profound difference to their life, or even their future. We and families affected by Duchenne muscular dystrophy will be demanding action on Wednesday, for the many children who cannot afford to wait."

Back to all posts


Written Answers — Department of Health: Air Pollution: Housing (17 Nov 2017)
Steve Brine: The World Health Organization's report, ‘Preventing Non-communicable Diseases by Reducing Environmental Risk Factors’, published on 12 September 2017, will be taken into consideration along with the rest of the relevant evidence base when developing cross-government policy. The Department of has recently asked the National Institute for Health and Care Excellence to develop...

Written Answers — Department of Health: Influenza: Vaccination (17 Nov 2017)
Steve Brine: Encouraging take-up of the flu vaccination in people with chronic respiratory disease is primarily a matter for Public Health England (PHE). PHE, in partnership with NHS England, is currently running the national multi-channel campaign ‘Stay Well This Winter’, which encourages people who are most at-risk of preventable emergency admission to hospital to take actions to help them...

Written Answers — Department of Health: Pupils: Diabetes (17 Nov 2017)
Steve Brine: The Department and its arm’s length bodies maintain a continuous dialogue with colleagues across government on a range of issues, including how best to meet the health needs of schoolchildren. It is important that children with medical conditions such as diabetes are supported appropriately. Statutory guidance for governing bodies of maintained schools and proprietors of academies in...


Contact Steve Brine in Westminster

Call your MP in his Commons office on 0207 219 7189 or email steve.brine.mp@parliament.uk

Early Day Motions (EDMs)

Steve Brine does not sign EDMs - click here to read why.

Facebook

Sign up to e-newsletter

Sign up for email updates:

First name: *

Last name: *

Email: *

Postcode: *